Haller Julia A sold $241K of BMY
Haller Julia A sold 3,800 shares of BRISTOL MYERS SQUIBB CO (BMY) at $63.31 ($0.24M total) on 2026-11-05.
How this was made
The 30-second read
Why it matters
The only new information is the reported sale details (shares, price, total value, post-transaction holdings). There is no mention of company performance, guidance, litigation, or corporate actions.
Market read
Traders may note insider selling optics, but the transaction size and lack of company-specific catalyst suggest limited impact on valuation.
What to watch
The filing does not indicate a 10b5-1 plan and does not provide intent; without additional context (other insider trades, earnings/guidance), the signal is weak.
Background
The article is a SEC Form 4 insider transaction disclosure for Bristol Myers Squibb director Haller Julia A.
Ticker impact
Bristol Myers Squibb director Haller Julia A sold 3,800 shares at $63.31 on 2026-11-05 via an open-market sale, per Form 4.
Likely limited, with modest selling-pressure optics rather than a fundamental repricing catalyst.
The disclosure is an insider transaction (Form 4) with relatively small dollar value and no accompanying company-specific operational or guidance change.
Market effects
Minimal; single-insider sale does not materially alter biotech/large-cap pharma sector expectations.
None.
None.
Counterpoint
Insider sales are often diversification or liquidity-driven and may not signal bearish views, especially without any follow-on buying or company news.
Key entities
- issuerBristol Myers Squibb
US-listed company whose director reported an open-market sale on Form 4.
- insiderHaller Julia A
Director who sold 3,800 shares at $63.31 on 2026-11-05.
